Trisalus Life Sciences

IPO

Home – Developing Treatments for Liver & Pancreatic Tumors

Public · Westminster, United States · Founded 2013 · $91.5M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$91.5M
Last Round
$22.0M Private EquityApr 2025
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 1 investor for this company. The full record is or through the API.

About

TriSalus Life Sciences develops and commercializes drug delivery technology for patients with liver and pancreatic tumors. Its Pressure-Enabled Drug Delivery (PEDD) approach modulates pressure and flow to improve therapy penetration and overcome intravascular barriers, and has been used in more than 18,000 procedures. The company also studies combining immunomodulation therapy with proprietary intravascular regional delivery across multiple clinical trials.

Summary

Trisalus Life Sciences is a Healthcare company based in Westminster, United States, founded in 2013. It has raised $91.5M in total across 5 rounds, most recently a $22.0M Private Equity round in Apr 2025. Investors include Nantahala Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate EquityApr 2025
$22.0M

Sign up to see all 6 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trisalus Life Sciences on Indexed.vc
<a href="https://indexed.vc/companies/trisalus-life-sciences"><img src="https://indexed.vc/api/badge/company/trisalus-life-sciences" alt="Trisalus Life Sciences on Indexed.vc" width="260" height="76" /></a>